A personalized medicine approach for beta-thalassemia transfusion dependent patients: testing SIROLIMUS in a first pilot clinical trial.
Latest Information Update: 11 Mar 2024
Price :
$35 *
At a glance
- Drugs Sirolimus (Primary)
- Indications Beta-thalassaemia
- Focus Therapeutic Use
- Acronyms SIRTHALACLIN
- 02 May 2022 Status changed from recruiting to completed.
- 07 Sep 2020 New trial record